Anti-PSMA (124)I-scFvD2B as a new immuno-PET tool for prostate cancer: preclinical proof of principle

Por Frigerio, B., Morlino, S., Luison, E., Seregni, E., Lorenzoni, A., Satta, A., Valdagni, R., Bogni, A., Chiesa, C., Mira, M., Canevari, S., Alessi, A., Figini, M.
Publicado no J Exp Clin Cancer Res (2019)